Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel treatments for orthopedic infections.
Osteal Therapeutics has raised $15.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Osteal Therapeutics's investors include Zimmer Biomet, Johnson & Johnson Development Corporation, Gideon Strategic Partners, GOS Capital, Johnson & Johnson Robotics and Digital Solutions.
Osteal Therapeutics is headquartered in Dallas, United States.
Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel treatments for orthopedic infections.
Osteal Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Osteal Therapeutics — Funding & Investors." VCBacked, November 5, 2025, https://www.vcbacked.co/company/osteal-therapeutics. Accessed August 15, 2026.
VCBacked. (2025). Osteal Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/osteal-therapeutics
{{cite web |title=Osteal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/osteal-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated